Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127599121 | 12759912 | 1 | I | 20160831 | 20160919 | 20160919 | EXP | TR-UNICHEM LABORATORIES LIMITED-UCM201609-000206 | UNICHEM | UZ Y,HARIRI A,UNUBOL H,BILICI M. STUPOR DUE TO POSSIBLE INTERACTION BETWEEN LORAZEPAM AND VALPROIC ACID: REPORT OF TWO CASES. TURKISH JOURNAL OF PSYCHIATRY 2012 DEC 01;23(4):1-2. | 26.00 | YR | F | Y | 0.00000 | 20160919 | OT | TR | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127599121 | 12759912 | 1 | PS | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Y | 79163 | 750 | MG | |||||||||
127599121 | 12759912 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | Y | 0 | 2.5 | MG | ||||||||
127599121 | 12759912 | 3 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 | 10 | MG | ||||||||||
127599121 | 12759912 | 4 | C | Biperiden | BIPERIDEN | 1 | 0 | 2 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127599121 | 12759912 | 1 | Hypomania |
127599121 | 12759912 | 2 | Anxiolytic therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127599121 | 12759912 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127599121 | 12759912 | Drug interaction | |
127599121 | 12759912 | Stupor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |